The SLAS Nominating Committee is pleased to announce these three SLAS Board of Directors candidates for four-year terms beginning in January 2027.
Per the Society’s policy, any SLAS member in good standing may submit a petition nominating an alternative candidate.
Formal petitions challenging a candidate may be submitted until October 9, 2026. Questions, comments and petitions should be emailed directly to SLAS CEO, Vicki Loise.
I have been a proud member of SLAS since 1998, when it was the Society for Biomolecular Screening (SBS). Early in my career, I was tasked with establishing an automated screening platform and quickly realized I needed guidance. Fortunately, I was introduced to SBS, where two members generously mentored and helped me troubleshoot the issues. That experience shaped my career and demonstrated the extraordinary value of the SLAS community.
I began attending SBS conferences—and later SLAS. The conferences were a catalyst for scientific learning, collaboration, and innovation, bringing together academic, industrial, and applied scientists to share ideas, challenge one another, and advance drug discovery. SBS became my scientific "family," and as it evolved into SLAS, its impact and sense of community only grew stronger. Inspired by those experiences, I became increasingly involved in serving the Society. Over the years, I have had the privilege of serving on the SBS Board of Directors, as Conference Co-Chair, a member of the SBS/SLAS Editorial Board(s) and SLAS Knowledge & Delivery Council, and as Editor-in-Chief of SLAS Discovery since 2018. Throughout these roles, I have worked alongside exceptional scientists who have continually challenged and inspired me.
My career in drug discovery now spans nearly four decades, including leadership roles at two major pharmaceutical companies, three biotechnology companies, and served as both a postdoctoral advisor and adjunct professor. While my career has evolved, my commitment to SLAS has remained constant. As an SLAS Board member, I would be honored to help position SLAS at the forefront of the rapidly evolving AI/ML revolution and its transformative applications in screening, laboratory automation, and drug discovery. Equally important, I would continue to foster collaboration, promote knowledge sharing, strengthen our sense of community, and help ensure that SLAS remains a leading force in advancing scientific discovery.
Our field is at a genuine inflection point. Technologies now exist that can meaningfully accelerate science, and I want to help SLAS take a leading role in that shift. That's why I'm seeking election to the SLAS Board of Directors.
For 25+ years I’ve worked at the intersection of laboratory automation, software and science, currently leading Digital Automation and Lab Experiment Systems at GSK and previously as CTO at Biosero, a lab automation solution provider. This gives a rare perspective across both the vendor landscape and end-user environments. At GSK, I’m driving the strategy for how AI, automation at scale and modern data infrastructure can really transform research, reshaping how experiments are designed, executed and interpreted, to deliver better science. That practical experience gives me a clear view of what is needed to move these technologies from promise to real scientific impact.
I’ve previously contributed to SLAS as a speaker and session chair, and through my board role with the SiLA Consortium I have worked on efforts around ANSI/SLAS standards. I want to build on that, helping educate the community on adopting new technologies across scientific applications, and fostering collaboration across the industry.
If elected, I would champion the following:
SLAS is well placed to help shape how this next generation of science is delivered. I would bring practical, cross-sector experience, a broad industry network and a strong commitment to connecting technology and science in ways that improve the speed, quality and impact of R&D.
I am writing with great enthusiasm to be considered for service on the SLAS Board. As a passionate and dedicated professional in the field of laboratory automation and high-throughput analysis, I firmly believe that my skills, experience, and commitment make me a suitable candidate for this esteemed position. I have been an active member and volunteer of the SLAS community.
I have been attending SLAS conferences, presenting multiple podium presentations and posters, publishing and serving as a reviewer for SLAS journals, serving as an Associate Editor for SLAS Technology, and engaging with fellow professionals. I have been honored to be named an SLAS Fellow in 2026. In addition, I have been a mentor in the SLAS community, helping other young scholars advance their careers. This firsthand involvement has given me a deep appreciation for SLAS's mission and values, as well as a comprehensive understanding of the challenges and opportunities the organization faces.
I have been leading the team developing the Acoustic Ejection Mass Spectrometry technology and collaborating with multidisciplinary teams. I have published more than 70 articles in respected scientific journals and hold more than 30 issued patents. I am the editor of a Wiley book “High-Throughput Mass Spectrometry in Drug Discovery”, and the recipient of Bioanalysis Outstanding Contribution Award (BOSCA) in 2021, and PerkinElmer Analytical Sciences and Spectroscopy Award in 2026. I am also the organizer of the 2026 ASMS Asilomar Conference themed High-Throughput Mass Spectrometry. This experience has honed my ability to navigate complex scientific landscapes, adapt to emerging technologies, and stay ahead of the curve in an ever-evolving field.
If selected to serve on the SLAS Board of Directors, I would be fully committed to advancing the organization's mission to foster innovation in life sciences and drive transformative change. I would work tirelessly to promote the professional development of members, expand networking opportunities, and strengthen partnerships with other scientific societies and industry leaders.
In conclusion, I am deeply passionate about the laboratory automation and high-throughput analysis field and dedicated to advancing its frontiers. My experience, leadership abilities, and commitment to SLAS make me a suitable candidate for a position on the Board of Directors. Given the opportunity, I am confident that I can contribute significantly to the growth and success of SLAS and its members.
